EVE Health Group Limited risk profile
66 Stretched several inputs deteriorating together
Measured 1 September 2026 from EVE's filed statements. Recomputed nightly.
66 (Stretched), driven by Competitive position at 86, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 81 | Acute | Stable | Drawdown from the 52-week high — 60.0% |
| Operating pressure | 35 | Normal | Worsening | Costs outgrowing revenue — +4.7 percentage points |
| Cash conversion | Reads operating_cashflow, capital_expenditure, free_cashflow, net_income and revenue. No reading is stored for this company. | |||
| Leverage and coverage | 42 | Elevated | Stable | Interest cover — -52.61x |
| Competitive position | 86 | Acute | Stable | Operating-margin gap against peers — -65.2 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 43Costco Wholesale Corp 40Coca-Cola Company 30Procter & Gamble Company 34Philip Morris International Inc 24Nestle S.A. 45Nestlé S.A 45L'Oréal S.A. 32PepsiCo Inc 43Anheuser-Busch InBev SA/NV 35Unilever plc 42Unilever PLC 42
Financials, valuation and price history for EVE Health Group Limited